Encodia Closes $75M Series C Financing Led by Northpond Ventures and Deerfield Management

Encodia, a privately held biotech company developing next-generation solutions for proteomics research, announced the closing of a $75 million Series C financing led by Northpond Ventures and Deerfield Management, joined by GV, Alexandria Venture Investments, and existing investors ARCH Venture Partners, Biomatics Capital, Decheng Capital, Tao Capital Partners, and Nan Fung Life Sciences. The investment … Read more

Notable Labs to Present Analysis of Hematologic Oncology Drug Sensitivity Data

Notable Labs, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced that it is hosting a live webinar on February 9 to unveil their integrative data platform. The Notable data scientists will share an in-depth discussion on how data generated from the functional and multi-omic drug sensitivity screen … Read more

BenchSci Listed as Best Workplace™ for Startups in Canada for 2nd Consecutive Year

BenchSci has been listed as a Best Workplace™ for Startups for the second consecutive year. This honor follows thorough and independent analysis by Great Place to Work® Institute Canada. BenchSci’s mission is to increase the speed and quality of life-saving research. The company provides AI-powered software for pharmaceutical research. Its platform empowers scientists to develop … Read more

TriRadial Solutions Names Michael Jensen Managing Director of Client Services

Global advisory firm TriRadial Solutions (www.triradial.com) has named life sciences executive Michael Jensen as Managing Director, Client Services. Jensen brings deep industry experience to support TriRadial’s mission to help emerging biopharma companies navigate productivity, partnerships and compliance. Jensen will leverage his extensive experience with pharma, biotech and medical device companies to identify and address key challenges that … Read more

InstantGMP™ Adds Learning Management System to InstantGMP™ PRO

InstantGMP™ has partnered with leading cloud-based training platform, Entrenar.se, to develop a fully integrated Learning Management System (LMS). This new solution allows supervisors to automate training assignments in a pre-defined order while employees are able to complete training on demand. In real-time, the LMS updates training logs and certifications to track progress and to help … Read more

Sentry Data Systems Earn Top Client Satisfaction Ratings in 340B Management Systems, Black Book Survey

Black Book Research announced that Sentry Data Systems achieved the top honor for highest user experience and outcomes in the annual customer polling of top 340B solutions’ customers. Black Book’s intensive study of 340B management systems included the input of pharmacy and financial leaders in hospitals, community health centers, government health agencies and clinics, and contract pharmacies … Read more

Orphan Drug Market Booming Thanks to More R&D, Competition and Innovation

Orphan drugs are used to treat orphan and rare diseases. The orphan drug industry is booming, with increasing focus from the pharmaceuticals industry focused on mitigating the toll that rare diseases have on the world’s population, according to the BCC Research report Drug Development in Rare Diseases: Focus on Clinical Trials and the Regulatory Landscape.  Factors boosting the market … Read more

Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area

Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, announced at the virtual grand opening ceremony on Jan. 20, 2021, the opening of its new 30,000-square-foot process development and cGMP manufacturing site in Waltham, Massachusetts. From cell line development to … Read more

Enalare Therapeutics Appoints Mark Coleman M.D. to Its Board of Directors

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions, announced today that it has appointed Mark Coleman M.D. to its Board of Directors. “We are very excited to have Dr. Coleman join our team,” stated Joe Pergolizzi MD, co-founder and Chief R&D Officer of Enalare. “Mark is a talented clinician, medical-scientist, and … Read more

InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization

InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Measles and Rubella (MR) antigen quantification kit.   Funded by the Bill and Melinda Gates Foundation with the goal of reducing the time and cost of manufacturing for these … Read more